InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: None

Thursday, 11/21/2013 7:38:39 PM

Thursday, November 21, 2013 7:38:39 PM

Post# of 146242
Remember this post? http://investorshub.advfn.com/boards/read_msg.aspx?message_id=92935215

The following is from FDA's "Father of GLP":

GLP is a regulation. It is not only good analytical practice. Good analytical practice is important, but it is not enough. For example, the laboratory must have a specific organizational structure and procedures to perform and document laboratory work. The objective is not only quality of data but also traceability and integrity of data. But the biggest difference between GLP and Non-GLP work is the type and amount of documentation.

For a GLP inspector it should be possible to look at the documentation and to easily find out

who has done a study,
how the experiment was carried out,-
which procedures have been used, and
whether there has been any problem and if so
how it has been solved.

And this should not only be possible during and right after the study has been finished but also 5 to 10 or more years later. ~ Father of GLP


http://www.labcompliance.com/tutorial/glp/

Monday's PR was just to let us know that NanoViricides, Inc. is moving along on projects/activities already known to us, on-track in a timeline.

What are we waiting for? The detailed report from KARD Scientific Boston that confirms "NanoViricides, Inc. (NNVC.PK) Says Early Results Indicate that FluCide® Was Extremely Safe in a Non-GLP Small Animal Tox Study" and indicates we are ready to move forward with the FluCide candidate GLP "tox studies". FluCide was also found to be "well tolerated". Nevertheless, as robi-1-kenobi stated on earlier post(s), we should move up huge. I am looking forward to 10-25% daily for 3 to 4 consecutive days, climbs that will take NNVC beyond 7.59 pps on 260K+ daily volume. You?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News